James C. Foster - 29 Jan 2024 Form 4 Insider Report for CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL)

Role
Chairman, President and CEO, Director
Signature
/s/ James C. Foster
Issuer symbol
CRL
Transactions as of
29 Jan 2024
Net transactions value
-$331,691
Form type
4
Filing time
31 Jan 2024, 16:59:40 UTC
Previous filing
15 Nov 2023
Next filing
20 Feb 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CRL Common Stock Options Exercise $2,522,466 +17,436 +8.3% $144.67 227,827 29 Jan 2024 Direct
transaction CRL Common Stock Tax liability $2,854,158 -12,710 -5.6% $224.56 215,117 29 Jan 2024 Direct
holding CRL Common Stock 7,580 29 Jan 2024 2022 GRAT F1
holding CRL Common Stock 20,000 29 Jan 2024 2023 GRAT
holding CRL Common Stock 340 29 Jan 2024 By Trust
holding CRL Common Stock 750 29 Jan 2024 By Trust
holding CRL Common Stock 2,250 29 Jan 2024 By Trust
holding CRL Common Stock 10,000 29 Jan 2024 Held By Spouse
holding CRL Common Stock 0 29 Jan 2024 2021 GRAT F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CRL Stock Options (Right to Buy) Options Exercise $0 -17,436 -100% $0.000000* 0 29 Jan 2024 Common Stock 17,436 $144.67 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On 11/20/2023, 3,420 shares were transferred from the 2022 GRAT account to Direct holdings.
F2 On 11/20/2023, 4,328 shares were transferred from the 2021 GRAT account to Direct holdings.
F3 The transaction was executed as a net exercise, in which no shares were purchased or sold in the open market.